Development of a quantitative RT-PCR for the human APO-1 (FAS/CD95) ligand and monitoring of ligand expression in normal and malignant T cells

被引：0
|
作者：
Herr, I
Balemans, L
Friesen, C
Debatin, KM
机构：
[1] UNIV HEIDELBERG,CHILDRENS HOSP,W-6900 HEIDELBERG,GERMANY
[2] GERMAN CANC RES CTR,DIV MOLEC ONCOL,W-6900 HEIDELBERG,GERMANY
来源：
BLOOD | 1995年 / 86卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：639 / 639
页数：1
相关论文
共 50 条
  • [31] Expression of Fas (APO-1/CD95) and Fas ligand in astrocytic brain tumors and the mechanisms of necrogenesis in glioblastomas
    Ohgaki, H
    Gratas, C
    Tohma, Y
    Tachibana, O
    Kleihues, P
    BRAIN PATHOLOGY, 1997, 7 (04) : 1183 - 1183
  • [32] Fas (APO-1/CD95) ligand and Fas expression in renal cell carcinomas - Correlation with the prognostic factors
    Kim, YS
    Kim, KE
    Choi, JA
    Lee, JH
    Kim, HK
    Won, NH
    Kim, I
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2000, 124 (05) : 687 - 693
  • [33] Ex vivo malignant glioma cells are sensitive to Fas (CD95/APO-1) ligand-mediated apoptosis
    Frei, K
    Ambar, B
    Adachi, N
    Yonekawa, Y
    Fontana, A
    JOURNAL OF NEUROIMMUNOLOGY, 1998, 87 (1-2) : 105 - 113
  • [34] Resistance to Fas (APO-1/CD95)-mediated apoptosis and expression of Fas ligand in esophageal cancer: the Fas counterattack
    O'Connell, J
    Bennett, MW
    O'Sullivan, GC
    Collins, JK
    Shanahan, F
    DISEASES OF THE ESOPHAGUS, 1999, 12 (02): : 83 - 89
  • [35] Fas antigen/APO-1 (CD95) expression on myeloma cells
    Shima, Y
    Nishimoto, N
    Yoshizaki, K
    Kishimoto, T
    LEUKEMIA & LYMPHOMA, 1996, 23 (5-6) : 521 - +
  • [36] Fas (CD95/APO-1) and Fas ligand expression in normal pancreas and pancreatic tumors - Implications for immune privilege and immune escape
    Bernstorff, WV
    Glickman, JN
    Odze, RD
    Farraye, FA
    Joo, HG
    Goedegebuure, PS
    Eberlein, TJ
    CANCER, 2002, 94 (10) : 2552 - 2560
  • [37] The CD95(APO-1/Fas) receptor/ligand system: Death signals and diseases
    Krammer, PH
    CELL DEATH AND DIFFERENTIATION, 1996, 3 (02): : 159 - 160
  • [38] INVOLVEMENT OF THE CD95 (APO-1/FAS) RECEPTOR AND LIGAND IN LIVER-DAMAGE
    GALLE, PR
    HOFMANN, WJ
    WALCZAK, H
    SCHALLER, H
    OTTO, G
    STREMMEL, W
    KRAMMER, PH
    RUNKELL, L
    JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (05): : 1223 - 1230
  • [39] DIFFERENTIAL EXPRESSION OF APO-1 (FAS/CD95) ON HUMAN HEMATOPOIETIC-CELLS
    STAHNKE, K
    KLEIHAUER, E
    DEBATIN, KM
    EXPERIMENTAL HEMATOLOGY, 1995, 23 (08) : 888 - 888
  • [40] Melanoma cell expression of fas(Apo-1/CD95) ligand: implications for tumor immune escape
    Science, 5291 (1363):
12345